Heartflow, Inc. (NASDAQ:HTFL) Receives Average Rating of “Moderate Buy” from Analysts

Heartflow, Inc. (NASDAQ:HTFL) has received an average recommendation of “Moderate Buy” from the eight analysts that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $38.50.

A number of research analysts have recently commented on HTFL shares. JPMorgan Chase & Co. increased their price target on Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Wells Fargo & Company started coverage on shares of Heartflow in a research report on Wednesday. They issued an “overweight” rating and a $38.00 price target for the company. Stifel Nicolaus boosted their price objective on shares of Heartflow from $35.00 to $40.00 and gave the stock a “buy” rating in a research note on Thursday, November 13th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Heartflow in a report on Monday, December 29th. Finally, Canaccord Genuity Group increased their price target on Heartflow from $39.00 to $40.00 and gave the company a “buy” rating in a research note on Thursday, November 13th.

Insider Buying and Selling

In other Heartflow news, Director Jeffrey C. Lightcap purchased 40,000 shares of Heartflow stock in a transaction that occurred on Tuesday, December 16th. The stock was acquired at an average price of $26.34 per share, with a total value of $1,053,600.00. Following the transaction, the director owned 40,000 shares in the company, valued at $1,053,600. This trade represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Institutional Investors Weigh In On Heartflow

Several large investors have recently made changes to their positions in the business. Wellington Management Group LLP bought a new position in shares of Heartflow during the 3rd quarter worth $164,263,000. Baillie Gifford & Co. purchased a new position in shares of Heartflow in the third quarter worth about $101,182,000. Schusterman Interests LLC bought a new stake in shares of Heartflow in the third quarter valued at approximately $65,274,000. Vanguard Group Inc. bought a new position in Heartflow in the 3rd quarter worth approximately $48,871,000. Finally, Capital International Investors purchased a new position in Heartflow in the 3rd quarter valued at approximately $43,671,000.

Heartflow Stock Down 0.9%

NASDAQ HTFL opened at $30.82 on Friday. The firm has a 50-day simple moving average of $30.73. The company has a market cap of $2.62 billion and a P/E ratio of -17.03. Heartflow has a 12-month low of $25.38 and a 12-month high of $41.22.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.